Elena Berelovich is Senior Vice President, Head of CMC at Prilenia. Elena has more than 25 years of experience in the pharmaceutical industry, leading a broad range of drug development CMC projects and activities, from lead-stage to Phase 3 and registration.

Elena previously served as Associate Director CMC Project Leader at the Innovative R&D at Teva Pharmaceuticals, leading diverse drug development projects throughout their life cycle. Her experience and responsibilities have involved management of all aspects of drug development, including sterile and oral dosage forms.

• 

  SVP, Head of CMC in Prilenia

  Pursuing Hope. Leading With Science.